---
Date Generated: June 16, 2025
Transcription Model: whisper medium 20231117
Length: 3503s
Video Keywords: ['Business of Biotech', 'Biopharma', 'Ecolab Life Sciences']
Video Views: 1
Video Rating: None
Video Description: On this week's episode of the Business of Biotech, Tom Wells, Director of Life Sciences at 4C Associates, reveals why -- and how -- smart procurement practices can make or break emerging biotech companies during critical growth stages. Tom shares insights into procurement tools and strategies that can deliver breakthrough solutions, how poor procurement practices can damage investor confidence, and why thinking about procurement as the front end of demand flow, not the back end of supply chain, can help drug developers avoid costly mistakes. 
This episode of the Business of Biotech is brought to you by Ecolab Life Sciences. Learn more at https://www.ecolab.com.
Subscribe to the podcast on your preferred platform or watch the videocast at lifescienceleader.com.
Access this and hundreds of episodes of the Business of Biotech videocast at lifescienceleader.com
***
#businessofbiotech #biopharma #biotech
Subscribe to the podcast:
Apple - https://podcasts.apple.com/us/podcast/business-of-biotech/id1508008606?uo=4
Spotify - https://open.spotify.com/show/5NhjpDeHzVlXPVqT9ezKwA
YouTube - https://www.youtube.com/playlist?list=PLFXsCNKV78rWNPmqIA8b2dKYLPYYv28wb
---

# Proactive Procurement Strategies For Biotech With Tom Wells
**Life Science Connect - Business of Biotech:** [June 15, 2025](https://www.youtube.com/watch?v=rGkIs2WA5tI)
*  This week's episode is brought to you by EcoLab. [[00:00:00](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=0.0s)]
*  Looking to lower production costs without compromising quality? [[00:00:03](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3.48s)]
*  Pyrrolite Purification Resins from EcoLab Life Sciences offer unmatched performance [[00:00:07](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=7.48s)]
*  with uniquely uniform beads for consistent results every time. [[00:00:13](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=13.48s)]
*  Plus, with dual-contentent supply, you get supply chain security you can count on. [[00:00:17](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=17.98s)]
*  Discover the power of pyrrolite resins at pyrroliteresins.com slash EcoLab. [[00:00:23](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=23.96s)]
*  That's P-U-R-O-L-I-T-E-R-E-S-I-N-S dot com slash E-C-O-L-A-B. [[00:00:29](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=29.96s)]
*  Welcome back to the Business of Biotech. [[00:00:43](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=43.96s)]
*  I'm your host, Ben Comer, Chief Editor at Life Science Leader, and today I'm thrilled [[00:00:46](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=46.46s)]
*  to speak with Tom Wells, Director of Life Sciences at 4C Associates, about procurement [[00:00:51](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=51.3s)]
*  practices, an issue that can stymie promising biotech companies during critical growth and [[00:00:57](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=57.9s)]
*  development stages if not done correctly. [[00:01:04](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=64.03999999999999s)]
*  Tom has worked in a variety of procurement roles at companies including Novartis, Takeda, [[00:01:06](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=66.97999999999999s)]
*  and most recently BMS before joining 4C Associates, a London-based commercial supply chain and [[00:01:12](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=72.25999999999999s)]
*  operations consultancy. [[00:01:19](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=79.72s)]
*  Tom is passionate about procurement and the ways it can impact a growing biotech business, [[00:01:22](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=82.08s)]
*  and I'm looking forward to learning more along with our Business of Biotech listeners about [[00:01:27](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=87.66s)]
*  how procurement can make or break biotech. [[00:01:32](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=92.0s)]
*  Tom, thank you so much for being here. [[00:01:35](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=95.0s)]
*  Pleasure to be here. [[00:01:37](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=97.2s)]
*  I mentioned in the introduction that you are passionate about procurement, an issue that [[00:01:39](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=99.56s)]
*  can be overlooked or under managed by growing companies despite its importance. [[00:01:45](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=105.1s)]
*  Why did you decide to spend the bulk of your career on procurement issues and how did you [[00:01:52](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=112.6s)]
*  get started in it initially? [[00:01:58](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=118.0s)]
*  Well, I actually started from university. [[00:01:59](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=119.74s)]
*  I read Boston University or Clang Science and then went into marketing, first of all [[00:02:02](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=122.69999999999999s)]
*  for a wine and spirit retail company in the UK, then moved to H.J. [[00:02:09](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=129.29999999999998s)]
*  Hines, the food company, as a brand manager. [[00:02:14](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=134.02s)]
*  From there, I went to various different marketing communications agencies based in London before [[00:02:17](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=137.3s)]
*  moving back in-house with Electrolux, the white goods company. [[00:02:24](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=144.22s)]
*  First of all, as head of corporate comms for Western Europe and then as head of brand PR [[00:02:29](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=149.02s)]
*  worldwide. [[00:02:34](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=154.18s)]
*  It was in that job that I really came across procurement for the first time. [[00:02:35](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=155.64000000000001s)]
*  Up to that point, my view probably would have been that procurement for those annoying [[00:02:40](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=160.74s)]
*  people who upset agencies, get contracts wrong, bungle payments and generally getting away [[00:02:45](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=165.3s)]
*  and that will slow things down. [[00:02:49](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=169.74s)]
*  But I was asked to help work on an internal campaign to reposition procurement in the [[00:02:51](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=171.54000000000002s)]
*  eyes of the business and help people understand what procurement is and what it actually does. [[00:02:57](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=177.70000000000002s)]
*  Which company was that? [[00:03:03](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=183.42000000000002s)]
*  This was Electrolux. [[00:03:06](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=186.06s)]
*  Okay. [[00:03:07](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=187.06s)]
*  Based on in Sweden. [[00:03:09](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=189.06s)]
*  And the program was all about repositioning procurements in the eyes of the business, [[00:03:11](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=191.74s)]
*  in the eyes of suppliers, trying to help people understand that procurement is actually, it's [[00:03:16](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=196.06s)]
*  not the back end of supply chain. [[00:03:19](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=199.82s)]
*  It's really the front end of demand flow. [[00:03:21](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=201.66s)]
*  It's the part of the business which can bring in new ideas, new suppliers, new ways of working [[00:03:24](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=204.42000000000002s)]
*  and so on. [[00:03:28](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=208.58s)]
*  But it did also make me think when I was working on that project, why is it that marketing [[00:03:30](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=210.12s)]
*  people such as me at the time, procurement people just weren't speaking when we're working [[00:03:35](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=215.58s)]
*  together and why were there so many of the cliches that marketing people thought of procurement [[00:03:40](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=220.58s)]
*  as being a difficult process by getting in the way, slowing things down, whereas procurement [[00:03:46](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=226.02s)]
*  people probably thought of marketing people as being spent through after-bill schools [[00:03:51](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=231.22000000000003s)]
*  and people who couldn't be trusted with money. [[00:03:54](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=234.70000000000002s)]
*  This came back a few years. [[00:03:57](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=237.06s)]
*  And the whole process is intriguing and eventually I decided it wouldn't it be great if procurement [[00:03:59](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=239.98000000000002s)]
*  people and marketing people could work more effectively together. [[00:04:05](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=245.42s)]
*  And I eventually left Electrolux to set up my own marketing procurement consultancy. [[00:04:09](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=249.17999999999998s)]
*  And I wasn't as much working on the sort of contracting and negotiations and pricing and [[00:04:14](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=254.06s)]
*  so on, but it was much more helping the client side of the relationship understand how agencies [[00:04:19](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=259.58s)]
*  work and like the best ways of working with the suppliers they're working with. [[00:04:26](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=266.21999999999997s)]
*  My view was then and always has been that you make it a little bit extra valuable in [[00:04:31](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=271.74s)]
*  short term if you try and negotiate with your agency to the suppliers on financial. [[00:04:36](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=276.58s)]
*  But if you understand how they work, how they make profit, what engages and motivates their [[00:04:43](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=283.90000000000003s)]
*  people and what it takes to help them develop their business as a result of the good work [[00:04:49](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=289.78000000000003s)]
*  they've done for you, then you'll find that that agency will give you infinitely greater [[00:04:54](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=294.82s)]
*  value than you could possibly get by trying to cut the price. [[00:05:00](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=300.06s)]
*  So I spent a few years running that consultancy business. [[00:05:04](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=304.26s)]
*  I worked with Coca-Cola and Pepsi in various different areas, with McDonald's Europe, with [[00:05:07](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=307.26s)]
*  General Motors Europe, but bit by bit I found myself working more and more with pharma companies. [[00:05:12](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=312.86s)]
*  And I guess that's because after the financial crash in 2007, 2008, governments, particularly [[00:05:19](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=319.1s)]
*  European governments, put a huge amount of money into supporting their currencies and [[00:05:25](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=325.74s)]
*  their markets. [[00:05:30](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=330.82s)]
*  They were looking to cut costs elsewhere and so started putting more pressure on pharmaceutical [[00:05:31](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=331.82s)]
*  companies, always an easy target for government which meet money, especially the big nasty [[00:05:38](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=338.06s)]
*  drugs companies. [[00:05:43](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=343.46000000000004s)]
*  In the five years to 2008, the average price of pharmaceuticals in Europe went up every [[00:05:45](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=345.38s)]
*  year. [[00:05:50](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=350.1s)]
*  In the five years after 2008, it went down as a year. [[00:05:51](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=351.1s)]
*  So pharma companies, particularly in the marketing area, needed to become much more [[00:05:55](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=355.5s)]
*  disciplined, much more savvy about what they were spending and how they were spending it. [[00:05:59](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=359.06s)]
*  And so I found myself working more and more for pharma companies. [[00:06:04](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=364.14s)]
*  And then one day I happened to approach from the Varsis in Switzerland, and work in global [[00:06:07](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=367.42s)]
*  catering needs for market research and then for marketing. [[00:06:15](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=375.34s)]
*  So moved the family to Switzerland, spent about five years with the Varsis, working [[00:06:18](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=378.86s)]
*  in marketing, marketing research, and then moved from the Varsis to Takeda as the global [[00:06:25](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=385.26s)]
*  procurement lead for travel, meet and host events. [[00:06:30](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=390.5s)]
*  And from there to Bristol Myers Squip, I moved from having sort of vertical global roles [[00:06:33](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=393.78s)]
*  to horizontal reaching roles, covering pretty much everything that the companies spend money [[00:06:38](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=398.78s)]
*  on. [[00:06:43](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=403.9s)]
*  And then up until the end of 2024, I was reaching the Canada, Latin America, Turkey, Israel, [[00:06:45](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=405.78s)]
*  and most of APEC. [[00:06:55](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=415.21999999999997s)]
*  And from there to Fawsey Associates at the beginning of March of this year. [[00:06:58](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=418.02s)]
*  I want to get your kind of broad definition of what procurement is and what it means to [[00:07:03](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=423.85999999999996s)]
*  you. And maybe as a way to start that conversation, could you describe kind of that transition [[00:07:10](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=430.02s)]
*  from marketing services into pharma and what the procurement job entailed? [[00:07:17](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=437.29999999999995s)]
*  Were there complete, I guess, analogous types of jobs that you were doing with pharma versus [[00:07:23](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=443.62s)]
*  with a consumer packaged goods company? [[00:07:31](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=451.38s)]
*  Were they issues similar or was there a kind of stark difference in the kinds of procurement [[00:07:33](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=453.7s)]
*  jobs that you were doing for pharma versus your prior work in consumer packaged goods? [[00:07:40](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=460.9s)]
*  Yeah, it's a good question. [[00:07:47](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=467.22s)]
*  I mean, I think that when it's being done properly, when it's being done well, [[00:07:48](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=468.26s)]
*  I think that the basics of procurement are the same across every industry. [[00:07:55](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=475.21999999999997s)]
*  So again, procurement is not the back end supply chain, but it's very much the front end of demand [[00:08:01](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=481.14s)]
*  flow. And it's the door to the rest of the world. It's the function which can bring in new ideas [[00:08:06](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=486.18s)]
*  and so on. And I think whichever industry you're in, it starts with having the knowledge [[00:08:13](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=493.46s)]
*  and the insights partner with the business. And in the case of life sciences, and this is different [[00:08:18](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=498.58s)]
*  from consumer goods or anything else, I think the key in the pharma industry is to be able to [[00:08:23](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=503.85999999999996s)]
*  understand the scientific and the business objectives and strategy and the priorities. [[00:08:29](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=509.29999999999995s)]
*  And that, I think, is the core difference. The life sciences across the piece, not just pharma, [[00:08:35](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=515.46s)]
*  but the agro-pathology life sciences, does need a really good understanding of how the business [[00:08:42](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=522.02s)]
*  works and how the science works. Otherwise, it's difficult to know what actually constitutes value [[00:08:47](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=527.6999999999999s)]
*  for your business. So in my case, I've been a procurement firm for quite some time. When I [[00:08:56](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=536.8199999999999s)]
*  was working at BMS, I realized that maybe my commercial understanding and my cross-function [[00:09:02](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=542.5s)]
*  understanding wasn't everything that others wanted to be. Bristol Myers Squibb has a wonderful [[00:09:09](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=549.06s)]
*  system called a tour of duty, which is to spend three months or six months in a completely difficult [[00:09:14](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=554.7399999999999s)]
*  crystal assumption, learning how things work, and just building your real perspective. So I actually [[00:09:19](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=559.9399999999999s)]
*  spent six months working at a commercial in BMS on a project to look at re-commercializing a bunch [[00:09:25](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=565.78s)]
*  of different drugs, which had a problem that had passed. And I was able to work across [[00:09:32](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=572.82s)]
*  regulatory VAP, forecasting, finance, production, and get many, many different functions. [[00:09:38](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=578.34s)]
*  That gave me a lot more understanding of the business and science, because I had to read [[00:09:44](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=584.98s)]
*  myself into the Journal of Transplantology, the British Journal of Nephrology, and many other [[00:09:51](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=591.62s)]
*  publications in order to be able to understand everything else that was happening with this [[00:09:57](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=597.46s)]
*  particular drug. So yeah, in any industry, it's about having the knowledge and the insights to [[00:10:01](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=601.38s)]
*  be a credible business partner, and to understand what the scientist is trying to do, what the [[00:10:07](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=607.38s)]
*  business is trying to do, what its strategies are, and what its priorities are. And from that, [[00:10:13](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=613.38s)]
*  I think you can start to identify the resources and the services that the business needs in order [[00:10:18](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=618.5s)]
*  to deliver that strategy and achieve those objectives. And from there, you can go out to [[00:10:24](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=624.5s)]
*  the board, external market, to look at all of the best possible providers, [[00:10:29](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=629.7s)]
*  answer for purposeful innovation, a reach for action to deliver this for a business. [[00:10:34](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=634.1800000000001s)]
*  Then obviously, negotiate and contract an onboard new supplier of the drug, maybe, [[00:10:39](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=639.46s)]
*  manage the risk and the client's issues, but to do all of that in a way which means you can build [[00:10:46](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=646.0200000000001s)]
*  a mutually productive relationship and low return value. And then obviously, work with this, [[00:10:52](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=652.4200000000001s)]
*  the stakeholders and the suppliers to maintain and to leverage those relationships for the loiter. [[00:10:58](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=658.98s)]
*  So most of those things are exactly the same for any industry. The part I think is key for [[00:11:06](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=666.1800000000001s)]
*  life sciences is that, is the ability to understand the science and the business of the science, [[00:11:12](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=672.1s)]
*  because that really does dictate everything else which you try and do. [[00:11:17](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=677.78s)]
*  When you say the back end, procurement should not be at the back end of the supply chain, [[00:11:21](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=681.86s)]
*  are you talking about the kind of tactical transactional role of procurement in negotiating [[00:11:26](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=686.42s)]
*  contracts, managing technical issues and compliance versus the front end of demand flow, [[00:11:35](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=695.6999999999999s)]
*  which I think I'm hearing you say is more relational, more holistic, gives you a sense of [[00:11:44](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=704.5799999999999s)]
*  the top priorities of the business and how to meet those requirements through procurement. [[00:11:50](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=710.82s)]
*  Is that correct? What would you add to that? [[00:11:58](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=718.98s)]
*  I think you need to have all of the end-to-end steps and everything actually at the back end, [[00:12:01](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=721.94s)]
*  the procurement processes of how do we write a contract, how do we negotiate, how do we pay [[00:12:07](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=727.86s)]
*  people, how do we manage inverses, how do we manage cash flow, all those things are [[00:12:12](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=732.58s)]
*  fundamental to procurement. They're far from value-less, they are critical, but they don't [[00:12:17](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=737.06s)]
*  necessarily add value. I think for the procurement function to add value, you need to put the answers [[00:12:25](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=745.2199999999999s)]
*  very much at the front end as well. To be able to take that proactive role in understanding, [[00:12:32](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=752.42s)]
*  not just what is it that someone wants me to buy, but what is it that the business or [[00:12:39](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=759.54s)]
*  person that's functioning actually needs in order to be able to operate and operate better [[00:12:45](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=765.06s)]
*  and add more value to business and ultimately more value for the patient. [[00:12:50](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=770.42s)]
*  So I think you need the backbone of procurement process and discipline and rigor and making sure [[00:12:55](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=775.62s)]
*  that everything is done correctly. There's a lot of compliance, one recognition, and we're dealing [[00:13:01](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=781.6999999999999s)]
*  with other people's money, but you need to add to that the scientific and business partnering to be [[00:13:05](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=785.9399999999999s)]
*  able to drive real value all the way through the chain. Right. As you say, money is kind of [[00:13:13](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=793.62s)]
*  at the root of procurement, you're spending money for services. What are some of the ways that early [[00:13:23](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=803.7s)]
*  stage biotechs can use procurement as a strategic tool to create value? Then we'll talk about on the [[00:13:30](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=810.42s)]
*  flip side of that, where companies go wrong with procurement to bad ends. [[00:13:39](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=819.38s)]
*  Yeah. Well, I think if you look at what actually is value for early stage biotechs, [[00:13:45](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=825.54s)]
*  it goes far beyond cost. Obviously, the money is important, but it's by balancing price and the [[00:13:52](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=832.02s)]
*  cost of operation. If you look at the money, there are really four things which you can do. You can [[00:13:58](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=838.34s)]
*  pay less, or you can pay smarter, or you can spend less, or you can spend smarter. In terms of [[00:14:03](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=843.22s)]
*  procurement managing how much do you spend and what's to be spent on, you need to balance each [[00:14:10](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=850.26s)]
*  of those four things. If you focus solely on how much do we pay and how can we pay less, [[00:14:16](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=856.4200000000001s)]
*  you might get to a situation where you've managed to persuade, bully, negotiate, whatever, a supplier [[00:14:23](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=863.14s)]
*  doing something for less. Are they going to be a resilient supplier? Are they going to really want [[00:14:29](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=869.22s)]
*  to do business with you? Do you run the risk of pushing the price you pay so low that you begin [[00:14:35](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=875.46s)]
*  to damage or to erode the goodwill of that supplier workbook for you? Managing the money side, [[00:14:41](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=881.38s)]
*  you've got to be holistic and think, pay less, pay smarter, spend less, spend smarter. Balance [[00:14:47](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=887.62s)]
*  those and you will get to a financial outcome. Where a problem with function for your team can [[00:14:52](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=892.98s)]
*  help is they can help anticipate and mitigate risk in supply chain. They can bring more [[00:15:03](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=903.94s)]
*  operational efficiency. They can help you get to market more quickly. In particular, they can help [[00:15:10](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=910.26s)]
*  you find innovative solutions and different ways of doing things. Not just different supplies, [[00:15:15](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=915.94s)]
*  but completely different ways of meeting opportunity or solving problems. [[00:15:20](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=920.9s)]
*  I think you can also help the business become a customer who the most critical suppliers most [[00:15:26](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=926.66s)]
*  want to do business with. I think in this increasing VUCA world that's built in, [[00:15:33](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=933.22s)]
*  I do think that's becoming more and more important. The way I've looked at it is that [[00:15:42](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=942.02s)]
*  as the world gets moreâ€¦ I'll take a bit back from that. The nature of new pharma products [[00:15:52](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=952.34s)]
*  is changing and we see there's a big shift towards smaller systems areas and more specialist [[00:16:00](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=960.98s)]
*  therapies. That means that the whole R&D process is getting much more complex and much more [[00:16:06](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=966.42s)]
*  expensive. That in turn means that supply chains are getting much more complicated and much more [[00:16:12](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=972.42s)]
*  expensive. In particular, much more complicated both upstream and downstream. Downstream, [[00:16:19](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=979.62s)]
*  if a patient has a wearable, they can actually become part of our supply chain because they can [[00:16:26](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=986.18s)]
*  be providing a Dixie which goes to their HCP. Their HCP might then pass it back to a [[00:16:31](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=991.38s)]
*  Dixie, Glomerator or a pharma company or whatever. The patient can actually become part of the entire [[00:16:36](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=996.58s)]
*  supply chain. What we see as a result of all of that is that the industry is becoming ever more [[00:16:43](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1003.78s)]
*  reliant on smaller and more specialist suppliers. The resilience of your supply chain, particularly [[00:16:50](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1010.18s)]
*  as a merchant biotech, becomes ever more critical because the question is, can you rely on your [[00:16:58](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1018.8199999999999s)]
*  supplier still being there in a year's time? As you're starting out down a long road using [[00:17:04](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1024.82s)]
*  someone else's money, you need to be able to pick suppliers to last the course and we'll get to [[00:17:11](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1031.7s)]
*  want to continue working with you. The power then starts to shift towards the supplier and you as [[00:17:18](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1038.34s)]
*  a specimen might begin to spend more on the supplier than they depend on you. That means [[00:17:26](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1046.9s)]
*  that you need to be the customer who they most want to do business with. You need to position [[00:17:33](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1053.8600000000001s)]
*  yourselves as the customer of choice. I think you see some great examples of this. I think the whole [[00:17:40](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1060.5s)]
*  area of regular politics is a great example where there are many, many therapies coming through [[00:17:49](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1069.8600000000001s)]
*  which have gravitated towards actinium isotopes. This will be the ideal isotope for many of these [[00:17:55](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1075.62s)]
*  therapies. There is still no reliable supply chain for the key isotopes of actinium. It is available, [[00:18:03](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1083.2199999999998s)]
*  but many, many companies are fighting to get their share of it. If you're a customer who has [[00:18:13](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1093.2199999999998s)]
*  habitually tried to force your supplier to take a lower price or we keep changing your mind or [[00:18:19](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1099.7s)]
*  messing up their workflow and their cash flow or if you talk about orders but then they're placed [[00:18:26](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1106.18s)]
*  in whatever field it is. If you're that kind of customer, when your supplier is under the same [[00:18:30](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1110.98s)]
*  kind of class, political, economic, social, technological, political stress that you are, [[00:18:38](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1118.18s)]
*  your supplier will become more wary. They want to concentrate on protecting their workflow, [[00:18:44](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1124.34s)]
*  their cash flow, their profitability. They will favor the customers who they trust most. [[00:18:50](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1130.18s)]
*  The question moves away from the area. It needs to be who do I trust as a supplier? Now I think it [[00:18:58](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1138.1s)]
*  has become a who trusts me. This is where procurement can play a key role for [[00:19:03](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1143.78s)]
*  emerging biotechs because I think that companies that are better able to explore new suppliers [[00:19:12](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1152.1s)]
*  but then engage more effectively with them and enable those suppliers to build their business [[00:19:18](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1158.98s)]
*  as a result are going to get a competitive advantage because they're going to be the ones [[00:19:24](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1164.58s)]
*  the customer with whom those suppliers will be most willing and most able to help [[00:19:29](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1169.3s)]
*  when we are in conditions of real operational stress. [[00:19:34](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1174.6599999999999s)]
*  How do companies position themselves as that customer of choice on a very specific level? [[00:19:39](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1179.46s)]
*  I mean is it the individuals that are negotiating the service orders and how that relationship [[00:19:48](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1188.34s)]
*  evolves? Are there other things that companies can do to kind of raise their profile with their [[00:19:58](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1198.26s)]
*  suppliers or endear themselves to suppliers so that they are kind of reaping the benefits [[00:20:06](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1206.18s)]
*  of that kind of relationship? There are a lot of things and they all come down to, [[00:20:13](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1213.46s)]
*  I was going to say human decency, they come down to behavior. It's all about treat people as you [[00:20:20](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1220.18s)]
*  want to be treated. And it's remember that even everyone at Beale's Supplies, they're people too, [[00:20:26](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1226.58s)]
*  they're trying to run their own businesses. And if you understand what pressures your supplier is [[00:20:33](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1233.3s)]
*  on to it, whether it's the pressures that you're under and trying to look at what would I want to [[00:20:40](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1240.4199999999998s)]
*  do, what's going to help us build a business relationship which actually goes beyond mere [[00:20:45](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1245.9399999999998s)]
*  bonds or beyond money, but actually helps us focus on not just on cost but on service, [[00:20:54](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1254.3400000000001s)]
*  on innovation, on to create the mutual maintenance. And it comes down ultimately to working [[00:21:02](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1262.0200000000002s)]
*  with people as people. And I think really that's it. In what I could call less sophisticated [[00:21:07](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1267.94s)]
*  procurement operations, you will very often find that there's an absolute focus on cost. [[00:21:18](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1278.9s)]
*  Yeah, we've got to meet the cost savings, we've got to get the price down. I want 10% off everything. [[00:21:24](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1284.26s)]
*  Well, in a VUCA world, and as I say, sometimes in a world which has gone from VUCA to WTF, [[00:21:28](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1288.9s)]
*  because that's the volatility of the terms that we now live in, is it more important to have the [[00:21:35](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1295.6200000000001s)]
*  lowest possible price? Or is it better to have a degree of sort of affordable confidence when, [[00:21:41](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1301.94s)]
*  okay, I probably could push the supply to a lower price, but do I want to? Because if I do, [[00:21:48](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1308.58s)]
*  I may get some small short-term advantage. Am I really giving myself a longer-term value? [[00:21:56](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1316.5s)]
*  So again, think of people as people and people as businesses are done by people. And start from that [[00:22:04](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1324.98s)]
*  basis. I think the basis of everything successful, particularly in a world like [[00:22:14](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1334.1s)]
*  procurement, is it's almost integrity and it's a degree of self-awareness. [[00:22:19](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1339.6999999999998s)]
*  Yeah. And Tom mentioned VUCA or the acronym for volatility, uncertainty, complexity, and ambiguity. [[00:22:26](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1346.6599999999999s)]
*  And moving to WTF, which I probably don't need to tell this audience what that stands for. [[00:22:34](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1354.5s)]
*  Your description of this relationship between the drug developer and suppliers, it sounds like [[00:22:40](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1360.82s)]
*  there really needs to be a kind of give and take there, a recognition of, to your point, [[00:22:47](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1367.94s)]
*  what the supplier needs to succeed in addition to what your own company needs to succeed. [[00:22:54](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1374.98s)]
*  And it's behavioral, it's people relationships is what you're saying. Is there anything else, [[00:23:02](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1382.18s)]
*  that you could say about maybe what companies specifically should think about when they're [[00:23:09](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1389.7s)]
*  engaging a supplier? Clearly, they want to help that supplier accomplish its goals, [[00:23:15](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1395.06s)]
*  but how do you understand what those goals are? How do you become that trusted partner that is [[00:23:20](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1400.74s)]
*  really aligned with a dual set of objectives? What are the great procurement acronyms? It's [[00:23:27](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1407.1399999999999s)]
*  APU-SCI, which has a security assurance, quality, service, cost, and innovation. [[00:23:35](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1415.7s)]
*  So when you're starting to work with a, when you're starting to look for suppliers, [[00:23:43](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1423.14s)]
*  you would start with assurance, which is, I didn't want to do two digits. Can I be sure that this [[00:23:48](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1428.5800000000002s)]
*  company exists? Can I be sure about its financial history? Do any of its directors and officers have [[00:23:53](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1433.06s)]
*  criminal records or all of those things? So I say, right, first of all, I'm sure myself about the [[00:23:58](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1438.3400000000001s)]
*  basic operating credentials of a potential supplier. Then I might look at the quality. [[00:24:04](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1444.5s)]
*  Can they do what they say they would? How do I know, how can I measure and manage the productivity? [[00:24:11](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1451.22s)]
*  What about how I'm looking to buy and so on? Then I would look at the service levels of what constitutes [[00:24:17](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1457.06s)]
*  good service to me and to my business. What is a, what are the sensible binnumers I should expect? [[00:24:25](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1465.14s)]
*  Should expect how quickly do I expect to be able to pull back if I have a problem? [[00:24:33](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1473.22s)]
*  Those are basic hygiene factors. Only then might I say, okay, if I've looked at various companies [[00:24:38](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1478.5s)]
*  and I've readied them out through the assurance, quality, and service levels, then I might look at [[00:24:45](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1485.06s)]
*  cost. And so, okay, of the ones who rule, I wrote my basic standards, which ones can give me the [[00:24:50](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1490.1s)]
*  best price or the best value. And then as a final differential factor, which ones can give me [[00:24:56](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1496.74s)]
*  information, can give me something extra, which maybe some of the other ones can't. [[00:25:04](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1504.66s)]
*  So those are the basic things which procurement should be set about to work for. But all of that [[00:25:09](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1509.22s)]
*  needs to be driven by a very clear understanding of what is it that my business actually needs. [[00:25:15](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1515.6200000000001s)]
*  And that's where the partnership starts. If you have a good, if the procurement team and [[00:25:21](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1521.94s)]
*  each different business function, they have a good relationship. It's based on, [[00:25:29](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1529.0600000000002s)]
*  yeah, mutual respect and understanding and the fact that they might understand what the [[00:25:32](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1532.9s)]
*  business is in terms of science and that we can have an intelligent conversation about the actual [[00:25:38](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1538.9s)]
*  problem and maybe help give other suggestions, bring in some new ideas. If we can build that [[00:25:46](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1546.34s)]
*  partnership, it's then much easier to build the third partnership, which is the supplier. [[00:25:52](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1552.1799999999998s)]
*  And then ideally, you would have your business stakeholder and your whole post-management [[00:25:58](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1558.98s)]
*  supplier working absolutely together as a threesome. It's not a different two-way relationship. You [[00:26:05](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1565.22s)]
*  really want to have it there as a threesome because again, that's what helps build the [[00:26:11](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1571.06s)]
*  familiarity that builds the trust and it builds the willingness to go a little bit further or to [[00:26:15](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1575.94s)]
*  offer a little bit more either when there's an opportunity or when there's a particular issue or [[00:26:22](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1582.82s)]
*  stress. Right. Let's talk about early stage biopharma companies. As a company grows, naturally, [[00:26:28](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1588.74s)]
*  it needs to acquire different and new resources, different kinds of services. I could think of a [[00:26:38](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1598.4199999999998s)]
*  situation where you have a scientific founder who maybe invented the platform technology, [[00:26:47](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1607.54s)]
*  is in the very earliest preclinical stages of development, but now is having to hire in [[00:26:53](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1613.78s)]
*  preparation for clinical trials, is having to add perhaps office space, is having to [[00:27:00](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1620.8999999999999s)]
*  purchase a lot of things that perhaps is a first-time purchase for that company. [[00:27:08](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1628.34s)]
*  What are some of those issues that you've encountered in your career or any kind of [[00:27:15](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1635.62s)]
*  examples that you can give where companies should be careful about how they are managing [[00:27:22](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1642.82s)]
*  that procurement process? Absolutely. I think there are two big inflection points in [[00:27:28](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1648.58s)]
*  the biopharma companies growth. The first really is moving from preclinical to clinical, [[00:27:34](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1654.42s)]
*  and then the second, further on down the line, is moving from clinical into commercial stage. [[00:27:40](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1660.3400000000001s)]
*  When you look at that jump from preclinical to clinical, I know that's a broad term, [[00:27:45](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1665.3000000000002s)]
*  and like you say, you suddenly need to start acquiring a whole lot of resources and services, [[00:27:50](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1670.5800000000002s)]
*  which may be scientific, so CROs, lab space, reagents, maybe data or whatever, [[00:27:55](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1675.78s)]
*  but also non-scientific. Suddenly, you start needing employees, so you need office space. [[00:28:01](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1681.78s)]
*  You might need cars. You need employee life assurance policies. You need primary market [[00:28:07](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1687.06s)]
*  research. You need law firms. You need marketing agencies. You need a coffee machine. You need [[00:28:12](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1692.02s)]
*  someone who's going to come in and change the flowers under the chef's desk once every [[00:28:17](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1697.54s)]
*  week. You suddenly start needing all of these different things, which first of all, a lot of [[00:28:21](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1701.54s)]
*  the complex, most of them tend to be expensive, and almost all of them, because this is [[00:28:26](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1706.34s)]
*  Flamanand, are very much burdened by compliance and by regulation. But the leadership team, [[00:28:31](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1711.6999999999998s)]
*  like say the scientific drivers of the business, seldom have very much expertise in planning, [[00:28:38](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1718.8999999999999s)]
*  spending in those areas. But very few preclinicians at that stage of growth have a procurement [[00:28:46](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1726.34s)]
*  team or a procurement person who's got the depth and breadth of skills and experience by them. [[00:28:53](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1733.86s)]
*  To negotiate for, or to find someone who can change the flower section that's been there a [[00:29:00](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1740.82s)]
*  week, a couple of weeks, not so differently, but to negotiate with the CRO, there you need [[00:29:05](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1745.3s)]
*  not just tactical expertise and negotiate with the CROs, but you need someone who can take a step [[00:29:10](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1750.82s)]
*  back and take the strategic view of what we're trying to do and how we'll be working with this [[00:29:15](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1755.3799999999999s)]
*  plant over the next two to three or four, whatever number it is. And so because the [[00:29:19](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1759.7s)]
*  early stage organisations seldom have that experience or expertise, it is very easy to [[00:29:27](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1767.3s)]
*  stand off by making mistakes, to build in indiscipline spending habits, or to waste or [[00:29:33](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1773.3s)]
*  maybe tie up funds that should actually be supported on the clinical agenda. And it's also [[00:29:41](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1781.06s)]
*  easy to miss opportunities for innovative approaches or for suppliers who can bring that [[00:29:48](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1788.18s)]
*  X factor because the overstressed e-shitting, they reach the providers they know, the people [[00:29:53](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1793.7s)]
*  they work with in the past because they feel they can trust them. That's not necessarily a bad thing, [[00:30:00](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1800.02s)]
*  but it can be limiting. I was talking to a sort of mid-tree blue stage some weeks back at a conference [[00:30:05](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1805.78s)]
*  with a few of the best people that I've seen, and they said, we don't have a problem with [[00:30:14](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1814.34s)]
*  children because we've all done this before, we know who we're going to work with. I said, yes, [[00:30:20](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1820.1s)]
*  what about all the ones which you don't know? What could you be missing? [[00:30:27](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1827.1399999999999s)]
*  And again, in these increasingly lucrative times, the LTs don't have the bandwidth either to be [[00:30:31](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1831.62s)]
*  managing currency fluctuations or worrying about their fragile supply chain or dealing with [[00:30:40](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1840.9s)]
*  flaky suppliers or chasing unpaid invoices. Those are all disciplines which they need to [[00:30:46](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1846.18s)]
*  be concentrated on building the business of driving the science, not all those sort of factors. [[00:30:51](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1851.7800000000002s)]
*  And they are really absolutely at their most exposed. [[00:30:57](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1857.46s)]
*  HOFFMAN You're absolutely right. People wear a lot of hats in early stage biotech. I could [[00:31:03](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1863.06s)]
*  understand that a procurement specialist may not be on staff, especially in the early days. Is it [[00:31:10](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1870.8999999999999s)]
*  your recommendation though that a company that is say, moving into clinical trials, scaling up [[00:31:18](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1878.82s)]
*  manufacturing, making a lot of purchases, even if they're not willing to pay a full-time salary to [[00:31:24](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1884.98s)]
*  a procurement person, should they consider a fractional kind of employee relationship or even [[00:31:32](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1892.02s)]
*  a part-time consultant? Or is it something that a company can work through or figure out itself? [[00:31:39](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1899.22s)]
*  I guess my question is, how do you go from this place of not knowing what you don't know to [[00:31:47](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1907.1399999999999s)]
*  being successful as a procurement manager at a small company that's rightly prioritizing their [[00:31:53](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1913.78s)]
*  science and data? HOFFMAN Well, obviously as a procurement consultancy, [[00:32:00](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1920.74s)]
*  I'm going to say they should definitely go into this too. Yeah, that's not the only answer. I [[00:32:06](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1926.18s)]
*  think there's a couple of things which every son should do when starting out. And the first is put [[00:32:13](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1933.94s)]
*  in place some just simple but effective procurement tools. There are many, many different [[00:32:18](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1938.9s)]
*  procurement digital solutions out there. They do tend to come and go pretty quickly. It's not [[00:32:25](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1945.38s)]
*  always easy to choose the most appropriate one, but it's not necessary. Yeah. What's your favorite [[00:32:32](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1952.66s)]
*  tool? Oh, very good question. I'm pretty much agnostic overall because different tools are [[00:32:39](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1959.54s)]
*  right for different businesses. I guess the one which I have most experience of is Zip, [[00:32:46](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1966.42s)]
*  which is a great procurement orchestration tool, a very fast growing company. There are many others, [[00:32:51](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1971.62s)]
*  I would say, for full disclosure. But what you want is something which is no more complicated than [[00:32:57](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1977.4599999999998s)]
*  needed to be. And so something that just means that when you're onboarding the supplier, when [[00:33:04](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1984.4199999999998s)]
*  you're processing invoices and payments, when he was looking at contracts and so on, you just want [[00:33:09](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1989.6999999999998s)]
*  everything to be as simple as possible to be in-bound plates and to be organized. Because [[00:33:15](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=1995.46s)]
*  you do not want that Friday morning or five o'clock something has gone wrong and now we've got to [[00:33:21](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2001.38s)]
*  source it. So just basic systems which don't actually expense it, don't actually become [[00:33:26](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2006.26s)]
*  data which can be scales to match the size of your business. I'd say that's an absolute fundamental. [[00:33:33](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2013.22s)]
*  So anyone like Zip or any of the other companies, they will help with the protection package. So you [[00:33:39](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2019.1399999999999s)]
*  don't have to do that work yourself. That I think will save you in so many other ways. [[00:33:46](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2026.82s)]
*  I mean, the other thing is just, I mean, there are many areas where you could simply do meet a [[00:33:53](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2033.78s)]
*  specialist person. Again, office space, you could probably negotiate that. But it's easy to tie [[00:33:59](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2039.7s)]
*  yourself in for very long leases without quite understanding the small print work. And it's easy [[00:34:07](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2047.38s)]
*  to limit to leasing company vehicles for longer or for more money than you need to. So you just [[00:34:14](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2054.82s)]
*  need to take careful steps and always try to get someone to, if it's an area you're well familiar [[00:34:21](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2061.78s)]
*  with, find someone who's going to check it for you. All right. And yes, that could be consulted. It [[00:34:27](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2067.78s)]
*  could be a part-time over long, but that probably could be helping at a more tactical level. [[00:34:33](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2073.46s)]
*  Where I think the biggest area of expense and complexity for early stage biotechs is the CRO [[00:34:39](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2079.7s)]
*  relationship. And we all know how complex, how sensitive, how happy those relationships can be. [[00:34:46](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2086.82s)]
*  And yeah, that's where it is critical to understand what am I actually procuring within this? So as [[00:34:57](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2097.2200000000003s)]
*  the sponsor, someone in the LTE and growing biotech, I've actually had a set of clinical [[00:35:05](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2105.5400000000004s)]
*  trials. Yeah, I know what I'm doing. I know how to project that. I know how to add that to, [[00:35:12](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2112.5s)]
*  yeah, we know what sort of sites we're looking for, what sort of patients we're looking for, [[00:35:18](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2118.1800000000003s)]
*  and all of those things. And they will then go and talk to a CRO. There are many different types [[00:35:21](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2121.86s)]
*  of CRO relationships. They all have their different pros and cons and so on. So as a sponsor, [[00:35:27](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2127.78s)]
*  you've got to find the right CRO and then come to the right sort of agreement with them. But I just [[00:35:33](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2133.0600000000004s)]
*  think it's essential that you have someone with a strategic procurement background behind that. [[00:35:38](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2138.7400000000002s)]
*  Because, okay, let's really go through, okay, and in detail, everything that might drive cost [[00:35:45](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2145.54s)]
*  and value for both partners in this. And it needs to be someone who is not afraid to probe [[00:35:52](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2152.74s)]
*  and to chariot both their own colleagues and the supplier until everyone fully understands [[00:36:01](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2161.8599999999997s)]
*  everybody else's priorities and needs and perspectives. And that means you need a lot [[00:36:09](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2169.14s)]
*  of what ifs in there as well. What if we don't manage to hit our improvement targets? What if [[00:36:14](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2174.5s)]
*  we have to maybe change the protocol for some reason to the same point? What additional costs [[00:36:21](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2181.14s)]
*  is that going to add? I think without a seasoned and experienced procurement person to look at it, [[00:36:25](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2185.3799999999997s)]
*  through that dispassionate lens, more scientific and non-business, okay, what do you need to really [[00:36:35](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2195.78s)]
*  agree here? Without that, it is very easy to focus too much on price, not that from value, [[00:36:44](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2204.26s)]
*  and to get locked into no-term agreements that consume money without actually having to make [[00:36:51](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2211.46s)]
*  a big deal out of it. Ultimately, I'd say, my parents were sheep farmers, sheep cattle farmers, [[00:36:56](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2216.1s)]
*  and one of my father's phrases was strong fences mid-good neighbors. So you really need to make [[00:37:05](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2225.2999999999997s)]
*  sure that everything is clarified. Even if people go, I know this, I've done it before. Okay, [[00:37:11](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2231.22s)]
*  let's write it down anyway. Because without that, it's too easy to not make mistakes, but maybe not [[00:37:17](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2237.14s)]
*  quite consider everything in the detail, which it needs to be considered in. You're talking about [[00:37:25](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2245.94s)]
*  multi-year relationships with many, many millions of dollars behind them. You've got to get it right. [[00:37:31](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2251.46s)]
*  And that does mean that it's just expertise and experience. [[00:37:38](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2258.58s)]
*  You mentioned earlier in our conversation, the potential for locking in poor procurement practices [[00:37:44](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2264.02s)]
*  at an early stage biotech company. And I wonder, clearly you don't want to spend any money that [[00:37:51](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2271.86s)]
*  is unnecessary or wasteful as a growing early stage biotech company. Managing finances is such [[00:37:58](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2278.5s)]
*  a critical piece of operations. But what kind of impact can that have, I guess, from an investor's [[00:38:06](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2286.02s)]
*  point of view? Do you risk compounding failure on failure by making some poor [[00:38:14](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2294.18s)]
*  procurement decisions early on when it comes to future fundraising? [[00:38:24](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2304.1s)]
*  Yeah, totally. That can definitely happen. So assuming you've got some funding, it could be [[00:38:29](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2309.54s)]
*  over-aggressive. Your current funders want to see evidence that their funds are being used [[00:38:36](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2316.98s)]
*  professionally and efficiently to drive the science and build a sound business. [[00:38:43](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2323.94s)]
*  And they don't want to see the funds being spent on it, which is unnecessary or [[00:38:48](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2328.82s)]
*  inappropriate for truth. And in the same way, future investors want to see the company's been [[00:38:55](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2335.78s)]
*  an effective steward of its previous funding and that it's likely to do so with future funding. [[00:39:00](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2340.98s)]
*  Because I think particularly in an environment where excess got more difficult, interest rates [[00:39:06](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2346.82s)]
*  are just more volatile. And then operation efficiency, if you go back a few years to [[00:39:12](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2352.7400000000002s)]
*  take us into more stable times, then investors would say, well, if I invest now, I'll sell out [[00:39:22](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2362.5s)]
*  in five years' time. It's the science which everything with profit and value. That's no longer [[00:39:26](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2366.9s)]
*  the case. So I think investors more and more are looking at the operational efficiency of their [[00:39:32](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2372.98s)]
*  investors because that can have a big impact on future valuations, particularly in this very [[00:39:40](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2380.26s)]
*  volatile world. Some of the bigger private equity firms have sometimes quite large value creation [[00:39:45](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2385.62s)]
*  teams, which are there to help their investors improve operation effectiveness, build their [[00:39:55](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2395.46s)]
*  supply chains, maybe down their procurement as well. But they have those teams to help their [[00:40:01](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2401.94s)]
*  investors because they see it as being an important contributor to go to the higher future valuations. [[00:40:10](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2410.02s)]
*  That sort of value creation team approach is unfortunately much less commonly available, [[00:40:18](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2418.02s)]
*  actually, at the early stages of drugs. But I think every company really needs to think, [[00:40:23](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2423.38s)]
*  how am I spending this much dollar? Could this be or should this be gained through my clinical [[00:40:29](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2429.78s)]
*  trials or shouldn't we spend some gain myself at BMW and so forth? [[00:40:35](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2435.94s)]
*  Right. I wanted to ask too about sourcing. If you're looking for actinium for a radiopharmaceutical, [[00:40:42](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2442.6600000000003s)]
*  you're fairly limited, as you said, to a couple of providers they're expanding right now, but [[00:40:53](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2453.86s)]
*  there are a number of different sources that different kinds of biotech companies need. [[00:40:58](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2458.98s)]
*  I wonder what you might say about the cutting edge of procurement as it relates to sourcing. [[00:41:06](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2466.7400000000002s)]
*  Are there different models, different innovative approaches to sourcing that you've experienced [[00:41:14](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2474.82s)]
*  in your career or that you see emerging at this point? [[00:41:21](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2481.7s)]
*  There are two really interesting areas. One is what I'd call innovative innovation. [[00:41:28](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2488.3399999999997s)]
*  Which is always worth thinking about is supplier diversity. [[00:41:34](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2494.1s)]
*  If we look at the first point, how do you look for innovation? If you always choose suppliers [[00:41:37](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2497.54s)]
*  by going through the traditional RFI, RFP approach, reaching to the traditional suppliers, [[00:41:44](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2504.2599999999998s)]
*  don't be surprised if you only get the traditional answers. [[00:41:50](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2510.58s)]
*  There are a whole range of techniques that you can use to go far beyond the traditional supply [[00:41:54](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2514.74s)]
*  base and solutions that can bring you. It's an RFI request for information, RFP request for [[00:42:00](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2520.2599999999998s)]
*  proposal. What would it get an RFO, which is a request for outcome? I guess a way that you [[00:42:06](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2526.8199999999997s)]
*  can think of it is sometimes you know exactly what the estimation is going to look like. [[00:42:12](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2532.8199999999997s)]
*  You don't know really what the resolution is going to look like. Sometimes you don't know [[00:42:17](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2537.7s)]
*  what the resolution is going to look like and you don't necessarily care what it looks like either. [[00:42:21](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2541.7s)]
*  Equally, sometimes you know exactly where your solution is going to come from [[00:42:26](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2546.58s)]
*  and sometimes you don't know or care where it's going to come from. [[00:42:30](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2550.58s)]
*  If you know exactly what you're looking for and you know pretty much what sort of company [[00:42:36](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2556.4199999999996s)]
*  it's going to come from, then just go to an RFP. I'd like to be a disabled. I want to please give [[00:42:39](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2559.8599999999997s)]
*  them the best price and all that it took. If I know pretty much what I'm looking for, [[00:42:45](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2565.78s)]
*  I don't know everywhere it comes from. Okay, RFI. I go to a wide group of companies and I say, [[00:42:51](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2571.78s)]
*  this is what I'm looking for. How much can you out in this area? Send me your outline, [[00:42:58](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2578.26s)]
*  your capabilities. Now we're going to decide which one to go for. [[00:43:03](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2583.86s)]
*  So if I know what sort of supplier I'm going to be looking at, which part of the supply-based [[00:43:07](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2587.86s)]
*  idea might come from, what solution I come from. But if I'm open to what that solution [[00:43:16](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2596.26s)]
*  actually looks like, then go for an RFO. Explain your circumstances to your superior to say, [[00:43:20](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2600.98s)]
*  help me solve this problem, but I'm not giving you any specific direction on what that solution [[00:43:28](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2608.6600000000003s)]
*  might look like. We'll start getting broader ideas, but from the same group of suppliers. [[00:43:35](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2615.94s)]
*  But sometimes you say, I'm trying to solve the problem. I don't know what my solution is. I [[00:43:42](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2622.58s)]
*  don't know where it's going to come from. So the sort of approach that is there is [[00:43:48](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2628.34s)]
*  local innovation. I'll give you an example. I'll say this is from a large US pharma company. I [[00:43:52](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2632.5s)]
*  won't name the name, but I was talking to one thing, Brown teams, and it's the classic [[00:44:00](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2640.58s)]
*  conversation, but simply what keeps you awake? What business problem do you really have to solve? [[00:44:06](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2646.8199999999997s)]
*  And they said, I've never met this drug. One of the things we love to be able to do is to assess [[00:44:12](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2652.18s)]
*  cognitive performance more effectively, because cognitive performance can actually be an earlier, [[00:44:18](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2658.5s)]
*  better indicator of progression or what would have been that. So that's the disease than the [[00:44:25](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2665.06s)]
*  usual tests of physical performance. But the problem is there'll be no advances in the way [[00:44:31](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2671.3s)]
*  that we measure cognitive performance for 20, 30, maybe 40 years. And the current tests that [[00:44:38](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2678.18s)]
*  repass it, so patients can actually learn how to do it, so we get artificially by school. [[00:44:45](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2685.14s)]
*  They take 14 words to be done. We have to do a more plentiful set and so on. So they're not [[00:44:50](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2690.66s)]
*  great. And should it be the brand being said, wouldn't it be great if there was a way of assessing [[00:44:56](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2696.66s)]
*  cognitive performance, which could be done by the patient themselves or maybe by the carer, [[00:45:04](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2704.2599999999998s)]
*  every day at home, take very good time to do it in a format which cannot be learned. So they [[00:45:09](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2709.14s)]
*  can't get better at the tests by repeating them, which would produce data which is reasonably [[00:45:15](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2715.22s)]
*  clinically robust and can be shared with their HOP or with their specialist. And of course, [[00:45:22](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2722.66s)]
*  there is no such solution. So we said, okay, let's see what we can do. We wrote up that [[00:45:29](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2729.54s)]
*  problem statement, put it on an open innovation platform, or was it? In the center of the world. [[00:45:36](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2736.58s)]
*  And we put that challenge out there to 500 or 600,000 people around the world who had [[00:45:43](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2743.94s)]
*  pre-registered as solvers on the open innovation platform. And within three months, we had about [[00:45:49](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2749.2200000000003s)]
*  135 responses, of which 120 plus were completely useless and within very degrees, many of them [[00:45:55](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2755.86s)]
*  were quite bad. But there were a handful, which you looked at, but actually that's a potentially [[00:46:06](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2766.1s)]
*  useful idea. And we eventually drilled down to three submissions, all of which were workable. [[00:46:11](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2771.94s)]
*  One of the winning ones, we're at $10,000, 19, the winning one, as I remember, came from a 25-year-old [[00:46:20](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2780.34s)]
*  grad student working in a real estate firm in the US. Another came from a retired mirror consultant [[00:46:28](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2788.9s)]
*  Canada. And the third one was an 18-year-old Spanish student based in London. So each of these [[00:46:35](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2795.7000000000003s)]
*  three solutions was completely workable. In fact, they've been developed further since, [[00:46:44](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2804.58s)]
*  but they all came from people who were so far outside any traditional supply base. [[00:46:50](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2810.1s)]
*  You couldn't imagine them being so good. But it's just about that by taking quite a structure, [[00:46:58](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2818.6600000000003s)]
*  deliberately wide range approach, we were able to put a problem or an issue that had not been [[00:47:05](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2825.38s)]
*  solved or developed in decades and come up with radical workable submissions within three months. [[00:47:13](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2833.3s)]
*  I know that that's just one example of how if you plan it carefully, then you really can come up with [[00:47:21](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2841.46s)]
*  genuinely distinctive and purposeful innovative solutions. [[00:47:32](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2852.18s)]
*  That's a great example. I had one follow-up I wanted to ask you on requests for outcome. [[00:47:37](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2857.94s)]
*  Is that a kind of tool that you're seeing more companies, I mean, is it a novelty at this point [[00:47:45](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2865.46s)]
*  to send out a request for outcome or more companies actually doing that at this point? [[00:47:51](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2871.2999999999997s)]
*  I guess it's more common in some areas than other. In, I guess, in their election trials, [[00:47:57](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2877.78s)]
*  for example, it's not that common though. I'm sure there are ways that it could be used. [[00:48:07](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2887.3s)]
*  But if you know there's something like marketing, then when you talk to your agency and say that [[00:48:13](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2893.46s)]
*  I want to increase sales by 10% for I want to increase my market share by whatever. [[00:48:18](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2898.82s)]
*  And I'm not really sure what sort of program or campaign I'm looking at. [[00:48:24](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2904.5800000000004s)]
*  Go away and brainstorm something, come back. That effectively is an RFO. [[00:48:30](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2910.02s)]
*  So I'm not saying, I could say I want a 30-second TV ad which is going to cover the following [[00:48:35](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2915.2200000000003s)]
*  explanation of clothes and will be broadcast on these channels at this time. Okay, that's [[00:48:41](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2921.5400000000004s)]
*  pretty specific. But if I say that my target audience are 35 to 45 year olds, men who [[00:48:46](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2926.34s)]
*  drive blue cars, wear yellow shirts and historically smoke too much. [[00:48:55](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2935.7000000000003s)]
*  I want to get them to change their, I want to sell more of their products and use them like buyers. [[00:49:01](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2941.2200000000003s)]
*  And I want to, the message I want to give them is, so what is the message which I want to give them [[00:49:07](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2947.7000000000003s)]
*  to make that change in behavior? How can I get that message to them? I don't know. You're the [[00:49:16](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2956.98s)]
*  kind of marketing agency you tell me. Matter of fact, that's an RFO. The skill is then taking [[00:49:22](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2962.5s)]
*  that RFO idea and then applying it in other areas of what you do. It's never going to work [[00:49:30](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2970.02s)]
*  for everything. And you need to know that you're going to be working with suppliers who you, [[00:49:37](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2977.22s)]
*  to some extent, already know trust. Another approach is more sort of co-development [[00:49:44](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2984.26s)]
*  goal or collaboration. But again, if I've got a supplier who I know well and I trust them and [[00:49:51](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2991.38s)]
*  have an existing relationship with them, and I might work with them on a particular product [[00:49:56](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=2996.9s)]
*  or service, I say let's build this together. And if it's successful, you'll obviously get paid for [[00:50:03](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3003.0600000000004s)]
*  implementing liver index and I'll get the revenue, whatever it is. Then let's actually trust each [[00:50:10](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3010.82s)]
*  other and work together to create something new. It's an extension of the RFO idea. It's not always [[00:50:16](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3016.9s)]
*  going to be suitable. It won't be suitable for every supplier, but when the partnership is there [[00:50:24](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3024.34s)]
*  and when the trust is there, it can really pay dividends. How far can you go, I wonder, in that [[00:50:29](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3029.94s)]
*  direction? When you were just talking, it reminded me of value-based contracts, which some companies [[00:50:36](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3036.66s)]
*  have started to work that essentially pay for outcomes. The health insurer will pay a certain [[00:50:43](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3043.62s)]
*  amount if the drug takes the patient to the desired outcome and will get rebated if the drug does not [[00:50:51](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3051.54s)]
*  take the patient to the outcome. I wonder to what extent that is happening, if at all, in other [[00:50:58](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3058.5s)]
*  aspects of pharma operations. For example, going to a CRO and saying our outcome, our expected [[00:51:05](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3065.22s)]
*  outcome is full recruitment by this date, this number of patients, and we're going to pay you [[00:51:14](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3074.4199999999996s)]
*  this amount of money. But if you don't reach that, if we have to delay the trial start or you have [[00:51:21](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3081.14s)]
*  problems with recruitment, then we get down to this next payment. Similarly with marketing [[00:51:26](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3086.98s)]
*  services, I don't know what the metrics would be, but it could be a certain number of doctors [[00:51:32](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3092.82s)]
*  are prescribing within a certain amount, whatever it is. Has it gone to that extent in procurement [[00:51:37](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3097.6200000000003s)]
*  in terms of the supplier having some skin in the game? Yes, sure. It's more common in some areas [[00:51:46](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3106.26s)]
*  than others. It's known as a pain share, game share, or bonus, or malice. The problems are, [[00:51:54](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3114.5800000000004s)]
*  and this is where I think it's a ticker problem in life sciences, biotech, because there are so [[00:52:02](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3122.66s)]
*  many potential variables. If you can link the outcome directly to the supplier's performance, [[00:52:10](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3130.2599999999998s)]
*  then great, they performed super well, they get bonus, they failed to perform, then they get [[00:52:18](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3138.3399999999997s)]
*  some kind of clawback. But there are so many potential factors that could have an impact. [[00:52:23](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3143.7s)]
*  The supplier could perform wonderfully, but the drug sales are what you want because a competitor [[00:52:32](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3152.5s)]
*  came out, because there was a new piece of data from another company. It could mean that there was [[00:52:39](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3159.62s)]
*  a supply chain problem, which meant that there was a supply chain problem available. It could be that [[00:52:46](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3166.18s)]
*  the sales source didn't get adequate breach. I think there are any one of many, many different [[00:52:51](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3171.14s)]
*  factors that could either genuinely or just by claim enable the supplier to say, well, I took [[00:52:56](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3176.98s)]
*  right out. The reason that the performance wasn't what was expected, it wasn't my fault. It was due [[00:53:06](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3186.34s)]
*  to whatever other factors. Where you can genuinely cut out all these other factors and say there is [[00:53:12](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3192.26s)]
*  a causal relationship between input and the fault. It's perfectly workable. If there are other factors [[00:53:18](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3198.34s)]
*  which are just uncontrollable, unpredictable variables, it will be more difficult. I think [[00:53:32](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3212.98s)]
*  that you see a lot of that in drug pricing. We can add with some examples of drug pricing. We'll [[00:53:40](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3220.9s)]
*  take your drug, you'll get better, factorably more like it. Or even say, [[00:53:46](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3226.9s)]
*  prescribe the drug. If you reimburse the drug and the patient gets better, pay me at the end or pay [[00:53:50](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3230.82s)]
*  me six months, the patient is still alive or whatever it might be. It was the patient's [[00:53:58](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3238.02s)]
*  keeping function continuous to do risk. You pay me, which changes. You stop paying it. [[00:54:05](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3245.46s)]
*  Whatever the rates might be. If you can really pin down absolutely clear links of cause and effect, [[00:54:09](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3249.94s)]
*  but it is just so difficult to do that. I think that's why there was initially a lot of excitement [[00:54:17](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3257.22s)]
*  about these value-based contracts, risk-based contracts. They didn't become as popular as I [[00:54:24](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3264.26s)]
*  think people initially expected because of that complexity. Comorbidities, lifestyle, [[00:54:31](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3271.22s)]
*  all sorts of inputs into the outcome that a drug can deliver that may not be able to be easily [[00:54:38](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3278.74s)]
*  accounted for in a contract. I do believe that data is always going to get bigger, [[00:54:46](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3286.4199999999996s)]
*  but as our ability to process and first of all to accumulate and analyze data and then desacricate [[00:54:54](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3294.2599999999998s)]
*  it, that is growing and growing every day. I do think that we will get to the point when it does [[00:55:01](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3301.22s)]
*  become increasingly possible to link cause and effects despite the many variables of the [[00:55:08](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3308.26s)]
*  background. Great. Well, we are running short on time here, Tom, but I want to give you just a [[00:55:16](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3316.0200000000004s)]
*  chance before we wrap up. If there are any last final thoughts that you have on this topic that [[00:55:22](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3322.0200000000004s)]
*  maybe you think are important that we haven't discussed, perhaps any advice you might have to [[00:55:28](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3328.5s)]
*  biotech builders working in a WTF world at the moment where there is a lot of uncertainty just [[00:55:34](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3334.66s)]
*  in terms of global economic policy, various conflicts around the world. What are your final [[00:55:43](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3343.46s)]
*  thoughts in terms of what early-stage and mid-stage biotech companies can do to stay on the right foot [[00:55:52](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3352.42s)]
*  with procurement or even use it to their advantage? There are some letters I would [[00:56:00](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3360.9s)]
*  highlight and they're not VUCA and they're not WTS. What I would always try and highlight is that [[00:56:08](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3368.02s)]
*  in the middle of the word procurement are the four letters C-U-R-E. I always do highlight them. I [[00:56:14](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3374.02s)]
*  have them on my email signature picked out in a different font color. I think the message [[00:56:22](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3382.26s)]
*  based for procurement people, but also for early-stage biotech is remember that if you [[00:56:31](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3391.2200000000003s)]
*  enable and encourage your procurement team or procurement partner to be the best they can and [[00:56:37](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3397.86s)]
*  to do the job that they can do, when the source and procurement functions are operating at its best, [[00:56:44](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3404.34s)]
*  we really can have as direct an impact on the patient as any other part of the function. [[00:56:52](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3412.1s)]
*  So I believe the cure is or should always be at the heart of what procurement does. [[00:56:59](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3419.86s)]
*  Engage us early, engage us deeply, trust us, let us be part of your business. Trust that we do have, [[00:57:07](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3427.62s)]
*  hopefully we have the scientific understanding and the business savvy to be able to contribute [[00:57:15](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3435.14s)]
*  as your strategic partner as well as your commercial backbone. Involve us in that way and [[00:57:20](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3440.26s)]
*  we will generally help you deliver a level of lasting value which you may be excited [[00:57:26](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3446.26s)]
*  from any other way. Excellent. Tom, thank you so much for being here today. It was an education [[00:57:32](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3452.6600000000003s)]
*  for me and I expect it will be for many of our listeners. I really appreciate it. [[00:57:39](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3459.7000000000003s)]
*  We've been speaking with Tom Wells, Director of Life Sciences at 4C Associates. I'm Ben Comer and [[00:57:46](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3466.98s)]
*  you've just listened to the Business of Biotech. Find us and subscribe anywhere you listen to [[00:57:53](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3473.14s)]
*  podcasts and be sure to check out new weekly video casts of these conversations every Monday [[00:57:58](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3478.02s)]
*  under the Business of Biotech tab at Life Science Leader. We'll see you next week and thanks for [[00:58:04](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3484.18s)]
*  listening. [[00:58:09](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3489.22s)]
*  you [[00:58:23](https://www.youtube.com/watch?v=rGkIs2WA5tI&t=3503.14s)]
